SCHEMBL38742

SCHEMBL38742

C=NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6271130 0.93
Iodide SCHEMBL5307298 0.93
Hydrochloric Acid SCHEMBL2073823 0.93
SCHEMBL12990319 0.68
SCHEMBL14682543 0.68
SCHEMBL905279 0.67
SCHEMBL903201 0.65
SCHEMBL1029 0.61
SCHEMBL70656 0.55
SCHEMBL6053895 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10640 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209375-A1 Aptamers For Personal Health Care Applications PROCTER & GAMBLE (US) 2024-06-27 US claimed
US-11946050-B2 Polynucleotide compositions and methods for gene expression regulations APTAH BIO, INC. (US) 2024-04-02 US claimed
EP-4320237-A1 OLIGONUCLEOTIDES Hudson Institute of Medical Research (AU) 2024-02-14 EP claimed
US-11859187-B2 Aptamers for personal health care applications THE PROCTER & GAMBLE COMPANY (US) 2024-01-02 US claimed
WO-2023220744-A2 SINGLE-STRANDED LOOP OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-11-16 WO claimed
US-20230348903-A1 OLIGONUCLEOTIDES Hudson Institute of Medical Research (AU) 2023-11-02 US claimed
US-20230340495-A1 APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS COMPANY, THE P&G 2023-10-26 US claimed
EP-4263835-A1 APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS The Procter & Gamble Company (US) 2023-10-25 EP claimed
US-20230287433-A1 APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS THE PROCTER & GAMBLE COMPANY 2023-09-14 US claimed
US-20230257745-A1 Circular siRNAs BANK OF AMERICA, N.A. 2023-08-17 US claimed
WO-1998023294-A1 AGENT AND METHOD OF TREATMENT FOR DISEASES AND CONDITIONS ASSOCIATED WITH RESPIRATORY AILMENTS AND LUNG INFLAMMATION EAST CAROLINA UNIVERSITY (US) 1998-06-04 WO claimed
WO-1997046570-A1 OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA ISIS PHARMACEUTICALS, INC. (US) 1997-12-11 WO claimed
WO-1997046569-A2 2'-SUBSTITUTED NUCLEOSIDES AND OLIGONUCLEOTIDE DERIVATIVES NOVARTIS AG (CH) 1997-12-11 WO claimed
US-5412100-A Fungicidal substituted acrylic esters BAYER AKTIENGESELLSCHAFT (DE) 1995-05-02 US claimed
EP-0384211-B1 Substituted acrylic-acid esters BAYER AG (DE) 1994-09-07 EP claimed
US-5114959-A FUNGICIDAL SUBSTITUTED ACRYLIC ESTERS BAYER AKTIENGESELLSCHAFT (DE) 1992-05-19 US claimed
EP-0384211-A2 Substituted acrylic-acid esters BAYER AG (DE) 1990-08-29 EP claimed
EP-0102271-B1 PROCESS FOR THE STABILISATION OF REACTIVE IMINES, STABLE IMINIUM SALTS OBTAINED BY THIS PROCESS AND THEIR USE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1986-01-08 EP claimed
EP-0102271-A1 Process for the stabilisation of reactive imines, stable iminium salts obtained by this process and their use CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1984-03-07 EP claimed
EP-0099329-A1 Dithio compounds, pharmaceutical preparations containing them and their use Zyma SA (CH) 1984-01-25 EP claimed